WESTBOROUGH, Mass., Nov. 14, 2013 /PRNewswire via COMTEX/ -- RXi Pharmaceuticals Corporation (otcqx:RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today reported its financial results for the quarter ended September 30, 2013, and provided a business update.
Help employers find you! Check out all the jobs and post your resume.
